ProstaLund AB (publ) 7PL.F Stock
ProstaLund AB (publ) Price Chart
ProstaLund AB (publ) 7PL.F Financial and Trading Overview
| ProstaLund AB (publ) stock price | 0.07 EUR |
| Previous Close | 0.14 EUR |
| Open | 0.13 EUR |
| Bid | 0.14 EUR x N/A |
| Ask | 0.19 EUR x N/A |
| Day's Range | 0.13 - 0.13 EUR |
| 52 Week Range | 0.12 - 0.45 EUR |
| Volume | 100 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 8.46M EUR |
| Beta (5Y Monthly) | 0.980842 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7PL.F Valuation Measures
| Enterprise Value | 7.72M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
ProstaLund AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.980842 |
| 52-Week Change | -65.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.45 EUR |
| 52 Week Low | 0.12 EUR |
| 50-Day Moving Average | 0.25 EUR |
| 200-Day Moving Average | 0.32 EUR |
7PL.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 57.19M |
| Float | 37.93M |
| Short Ratio | N/A |
| % Held by Insiders | 49.28% |
| % Held by Institutions | 1.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -66.060% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 70.31% |
| EBITDA Margin | -63.99% |
Management Effectiveness
| Return on Assets (ttm) | -16.96% |
| Return on Equity (ttm) | -34.080% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 22.19% |
| Gross Profit (ttm) | 12.87M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 4.25 EUR |
| Current Ratio (mrq) | 3.364 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of ProstaLund AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | Scheelevägen 19 |
| ZIP | 223 63 |
| Phone | 46 46 12 09 08 |
| Website | https://prostalund.se |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow soft stent; Oruflow, a urine flow meter; Dosi-Fuser, a disposable continuous infusion system; and Dosi-Flow, a gravitation unit with a flow regulator for dosing of medicines. The company also provides Schelin Catheter, an injection tool that allows the urologists to administer drugs into the prostate in a sterile way through the urethra. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Q&A For ProstaLund AB (publ) Stock
What is a current 7PL.F stock price?
ProstaLund AB (publ) 7PL.F stock price today per share is 0.07 EUR.
How to purchase ProstaLund AB (publ) stock?
You can buy 7PL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ProstaLund AB (publ)?
The stock symbol or ticker of ProstaLund AB (publ) is 7PL.F.
Which industry does the ProstaLund AB (publ) company belong to?
The ProstaLund AB (publ) industry is Medical Care Facilities.
How many shares does ProstaLund AB (publ) have in circulation?
The max supply of ProstaLund AB (publ) shares is 99.32M.
What is ProstaLund AB (publ) Price to Earnings Ratio (PE Ratio)?
ProstaLund AB (publ) PE Ratio is now.
What was ProstaLund AB (publ) earnings per share over the trailing 12 months (TTM)?
ProstaLund AB (publ) EPS is -0.02 EUR over the trailing 12 months.
Which sector does the ProstaLund AB (publ) company belong to?
The ProstaLund AB (publ) sector is Healthcare.